1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina C.; Bajaj, Anshika; Archer, Jacob F.; Reeves, Rebecca S.; Ngo, Lisa Y.; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fu... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma. Issue 1 (20th September 2016) Authors: Buchbinder, Elizabeth I.; Gunturi, Anasuya; Perritt, Jessica; Dutcher, Janice; Aung, Sandra; Kaufman, Howard L.; Ernstoff, Marc S.; Miletello, Girald P.; Curti, Brendan D.; Daniels, Gregory A.; Patel, Sapna P.; Kirkwood, John M.; Hallmeyer, Sigrun; Clark, Joseph I.; Gonzalez, Rene; Richart, John ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bempegaldesleukin Plus Nivolumab in First-Line Metastatic Melanoma. Issue 26 (10th September 2021) Authors: Diab, Adi; Tykodi, Scott S.; Daniels, Gregory A.; Maio, Michele; Curti, Brendan D.; Lewis, Karl D.; Jang, Sekwon; Kalinka, Ewa; Puzanov, Igor; Spira, Alexander I.; Cho, Daniel C.; Guan, Shanhong; Puente, Erika; Nguyen, Tuan; Hoch, Ute; Currie, Sue L.; Lin, Wei; Tagliaferri, Mary A.; Zalevsky, Jon... Journal: Journal of clinical oncology Issue: Volume 39:Issue 26(2021) Page Start: 2914 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical Responses of Oncolytic Coxsackievirus A21 (V937) in Patients With Unresectable Melanoma. Issue 34 (1st December 2021) Authors: Andtbacka, Robert H. I.; Curti, Brendan; Daniels, Gregory A.; Hallmeyer, Sigrun; Whitman, Eric D.; Lutzky, Jose; Spitler, Lynn E.; Zhou, Karl; Bommareddy, Praveen K.; Grose, Mark; Wang, Meihua; Wu, Cai; Kaufman, Howard L. Journal: Journal of clinical oncology Issue: Volume 39:Issue 34(2021) Page Start: 3829 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Development of Care Pathways to Standardize and Optimally Integrate Multidisciplinary Care for Head and Neck Cancer. Issue 6 (2nd November 2018) Authors: Sacco, Assuntina G.; Coffey, Charles S.; Sanghvi, Parag; Rubio, Gloria P.; Califano, Joseph; Athas, Jayna; Tamayo, Geline J.; Linnemeyer, Kristen; Barnachea, Linda C.; Orosco, Ryan K.; Brumund, Kevin T.; Cohen, Ezra E.W.; Gold, Kathryn; Mell, Loren K.; Sharabi, Andrew; Daniels, Gregory A.; Abbott... Journal: Oncology issues Issue: Volume 33:Issue 6(2018) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Drug therapy of advanced cutaneous squamous cell carcinoma: is there any evidence?. Issue 2 (March 2017) Authors: Ribero, Simone; Stucci, Luigia Stefania; Daniels, Gregory A.; Borradori, Luca Journal: Current opinion in oncology Issue: Volume 29:Issue 2(2017:Mar.) Page Start: 129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Genomic landscape of advanced basal cell carcinoma: Implications for precision treatment with targeted and immune therapies. (4th March 2018) Authors: Goodman, Aaron M.; Kato, Shumei; Cohen, Philip R.; Boichard, Amélie; Frampton, Garrett; Miller, Vincent; Stephens, Philip J.; Daniels, Gregory A.; Kurzrock, Razelle Journal: Oncoimmunology Issue: Volume 7:Number 3(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIMSM registry. Issue 1 (19th December 2017) Authors: Curti, Brendan; Daniels, Gregory A.; McDermott, David F.; Clark, Joseph I.; Kaufman, Howard L.; Logan, Theodore F.; Singh, Jatinder; Kaur, Meenu; Luna, Theresa L.; Gregory, Nancy; Morse, Michael A.; Wong, Michael K. K.; Dutcher, Janice P. Journal: Journal for immunotherapy of cancer Issue: Volume 5:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Incidence of Thyroid Function Test Abnormalities in Patients Receiving Immune‐Checkpoint Inhibitors for Cancer Treatment. (16th May 2018) Authors: Patel, Nisha Subhash; Oury, Anais; Daniels, Gregory A.; Bazhenova, Lyudmila; Patel, Sandip Pravin Journal: Oncologist Issue: Volume 23:Number 10(2018) Page Start: 1236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Infliximab for treatment-refractory transverse myelitis following immune therapy and radiation. Issue 1 (22nd December 2018) Authors: Chang, Victoria A.; Simpson, Daniel R.; Daniels, Gregory A.; Piccioni, David E. Journal: Journal for immunotherapy of cancer Issue: Volume 6:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗